Successful treatment of recalcitrant pemphigus foliaceus with rituximab

Journal of the European Academy of Dermatology and Venereology

Volumn 22, Issue 6, 2008, Pages 768-770

  Serrao V V ^a   Martins, A ^a   Paris F R ^a   Lopes, M P ^a  

^a HOSPITAL DOS CAPUCHOS   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; DAPSONE; DEFLAZACORT; DESMOGLEIN 1 ANTIBODY; IMMUNOGLOBULIN; PREDNISONE; RITUXIMAB;

ADULT; ANTIGEN DETECTION; BACK; CASE REPORT; COMBINATION CHEMOTHERAPY; DISEASE CONTROL; DISEASE EXACERBATION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MEGADOSE; DRUG RESPONSE; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FACE; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; HUMAN; IMMUNOFLUORESCENCE TEST; LETTER; MONOTHERAPY; PEMPHIGUS FOLIACEUS; PLASMAPHERESIS; PRIORITY JOURNAL; SEPSIS; THIGH; UNSPECIFIED SIDE EFFECT;

ANTIBODIES, MONOCLONAL; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; MIDDLE AGED; PEMPHIGUS; TREATMENT OUTCOME;

EID: 43649097177     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2007.02450.x     Document Type: Letter

References (8)

1. Yeh SW, Ahmed B, Sami N, Razzaque Ahmed A. Blistering disorders: diagnosis and treatment. Dermatol Ther 2003; 16: 214-223.
2. Whittock NV, Bower C. Targetting of desmoglein 1 in inherited and acquired skin diseases. Clin Exp Dermatol 2003; 28: 410-415.
3. El Tal AK, Posner MR, Spigelman Z, Ahmed AR. Rituximab: A monoclonal antibody to CD20 used in the treatment of pemphigus vulgaris. J Am Acad Dermatol 2006; 55: 449-459.
4. Fatourechi MM, el-Azhary RA, Gibson LE. Rituximab: Applications in dermatology. Int J Dermatol 2006; 45: 1143-1155.
5. Arin MJ, Engert A, Krieg T, Hunzelmann N. Anti-CD20 monoclonal antibody (rituximab) in the treatment of pemphigus. Br J Dermatol 2005; 153: 620-625.
6. Graves JE, Nunley K, Heffernan MP. Off-label uses of biologics in dermatology. rituximab, omalizumab, infliximab, etanercept, adalimumab, efalizumab, and alefacept (part 2 of 2). J Am Acad Dermatol 2007; 56: e55-e79.
7. Goebeler M, Herzog S, Brocker EB, Zillikens D. Rapid response of treatment-resistant pemphigus foliaceus to the anti-CD20 antibody rituximab. Br J Dermatol 2003; 149: 899-901.
8. Salopek TG, Logsetty S, Tredget EE. Anti-CD20 chimeric monoclonal antibody (rituximab) for the treatment of recalcitrant, life-threatening pemphigus vulgaris with implications in the pathogenesis of the disorder. J Am Acad Dermatol 2002; 47: 785-788.